
GOCO Valuation
Gohealth Inc
GOCO Relative Valuation
GOCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GOCO is overvalued; if below, it's undervalued.
Historical Valuation
Gohealth Inc (GOCO)  is now in the Fair zone, suggesting that its current forward PS ratio of 3.96 is considered Fairly compared with the five-year average of -16.92. The fair price of Gohealth Inc (GOCO) is between  to  according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:3.82
Fair
-2.05
PE
1Y
3Y
5Y
Trailing
Forward
6.32
EV/EBITDA
Gohealth Inc. (GOCO) has a current EV/EBITDA of 6.32. The 5-year average EV/EBITDA is 11.07. The thresholds are as follows: Strongly Undervalued below -1.31, Undervalued between -1.31 and 4.88, Fairly Valued between 17.27 and 4.88, Overvalued between 17.27 and 23.46, and Strongly Overvalued above 23.46. The current Forward EV/EBITDA of 6.32 falls within the Historic Trend Line -Fairly Valued range.
52.80
EV/EBIT
Gohealth Inc. (GOCO) has a current EV/EBIT of 52.80. The 5-year average EV/EBIT is -1.40. The thresholds are as follows: Strongly Undervalued below -112.65, Undervalued between -112.65 and -57.02, Fairly Valued between 54.23 and -57.02, Overvalued between 54.23 and 109.86, and Strongly Overvalued above 109.86. The current Forward EV/EBIT of 52.80 falls within the Historic Trend Line -Fairly Valued range.
3.96
PS
Gohealth Inc. (GOCO) has a current PS of 3.96. The 5-year average PS is 0.31. The thresholds are as follows: Strongly Undervalued below -0.47, Undervalued between -0.47 and -0.08, Fairly Valued between 0.70 and -0.08, Overvalued between 0.70 and 1.09, and Strongly Overvalued above 1.09. The current Forward PS of 3.96 falls within the Strongly Overvalued range.
33.80
P/OCF
Gohealth Inc. (GOCO) has a current P/OCF of 33.80. The 5-year average P/OCF is 0.28. The thresholds are as follows: Strongly Undervalued below -36.22, Undervalued between -36.22 and -17.97, Fairly Valued between 18.52 and -17.97, Overvalued between 18.52 and 36.77, and Strongly Overvalued above 36.77. The current Forward P/OCF of 33.80 falls within the Overvalued range.
-2.18
P/FCF
Gohealth Inc. (GOCO) has a current P/FCF of -2.18. The 5-year average P/FCF is 1.55. The thresholds are as follows: Strongly Undervalued below -29.59, Undervalued between -29.59 and -14.02, Fairly Valued between 17.12 and -14.02, Overvalued between 17.12 and 32.69, and Strongly Overvalued above 32.69. The current Forward P/FCF of -2.18 falls within the Historic Trend Line -Fairly Valued range.
Gohealth Inc (GOCO) has a current Price-to-Book (P/B) ratio of 0.23. Compared to its 3-year average P/B ratio of 0.49 , the current P/B ratio is approximately -53.13% higher. Relative to its 5-year average P/B ratio of 0.87, the current P/B ratio is about -73.25% higher. Gohealth Inc (GOCO) has a Forward Free Cash Flow (FCF) yield of approximately -95.07%. Compared to its 3-year average FCF yield of 2.86%, the current FCF yield is approximately -3426.65% lower. Relative to its 5-year average FCF yield of -55.61% , the current FCF yield is about 70.96% lower.
0.23
P/B
Median3y
0.49
Median5y
0.87
-95.07
FCF Yield
Median3y
2.86
Median5y
-55.61
Competitors Valuation Multiple
The average P/S ratio for GOCO's competitors is 10.26, providing a benchmark for relative valuation. Gohealth Inc Corp (GOCO) exhibits a P/S ratio of 3.96, which is -61.39% above the industry average. Given its robust revenue growth of -11.17%, this premium appears unsustainable. 
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GOCO  decreased by 70.18% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -56.03 to -123.33.
The secondary factor is the Revenue Growth, contributed -11.17%to the performance.
Overall, the performance of GOCO in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

CUB
Lionheart Holdings
10.620
USD
0.00%

NRGV
Energy Vault Holdings Inc
3.330
USD
-5.93%

TTSH
Tile Shop Holdings Inc
6.240
USD
-0.32%

TATT
TAT Technologies Ltd
41.760
USD
-0.57%

SIMA
SIM Acquisition I Corp
10.510
USD
-0.47%

COFS
ChoiceOne Financial Services Inc
28.890
USD
+0.87%

TSHA
Taysha Gene Therapies Inc
4.460
USD
-10.08%

PBPB
Potbelly Corp
0
USD
+0.06%

ORN
Orion Group Holdings Inc
10.820
USD
+0.46%

PDLB
Ponce Financial Group Inc
14.070
USD
-0.28%
FAQ
Is Gohealth Inc (GOCO) currently overvalued or undervalued?
Gohealth Inc (GOCO) is now in the Fair zone, suggesting that its current forward PS ratio of  3.96 is considered Fairly compared with the five-year average of -16.92. The fair price of  Gohealth Inc (GOCO) is between  to  according to relative valuation methord.









